Browsing by Author "Airola, Antti"
Now showing 1 - 4 of 4
Results Per Page
Sort Options
Item Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors(2017-08-01) Cichonska, Anna; Ravikumar, Balaguru; Parri, Elina; Timonen, Sanna; Pahikkala, Tapio; Airola, Antti; Wennerberg, Krister; Rousu, Juho; Aittokallio, Tero; Department of Computer Science; Professorship Rousu Juho; Helsinki Institute for Information Technology (HIIT); University of Helsinki; University of TurkuDue to relatively high costs and labor required for experimental profiling of the full target space of chemical compounds, various machine learning models have been proposed as cost-effective means to advance this process in terms of predicting the most potent compound-target interactions for subsequent verification. However, most of the model predictions lack direct experimental validation in the laboratory, making their practical benefits for drug discovery or repurposing applications largely unknown. Here, we therefore introduce and carefully test a systematic computational-experimental framework for the prediction and pre-clinical verification of drug-target interactions using a well-established kernel-based regression algorithm as the prediction model. To evaluate its performance, we first predicted unmeasured binding affinities in a large-scale kinase inhibitor profiling study, and then experimentally tested 100 compound-kinase pairs. The relatively high correlation of 0.77 (p < 0.0001) between the predicted and measured bioactivities supports the potential of the model for filling the experimental gaps in existing compound-target interaction maps. Further, we subjected the model to a more challenging task of predicting target interactions for such a new candidate drug compound that lacks prior binding profile information. As a specific case study, we used tivozanib, an investigational VEGF receptor inhibitor with currently unknown off-target profile. Among 7 kinases with high predicted affinity, we experimentally validated 4 new off-targets of tivozanib, namely the Src-family kinases FRK and FYN A, the non-receptor tyrosine kinase ABL1, and the serine/threonine kinase SLK. Our sub-sequent experimental validation protocol effectively avoids any possible information leakage between the training and validation data, and therefore enables rigorous model validation for practical applications. These results demonstrate that the kernel-based modeling approach offers practical benefits for probing novel insights into the mode of action of investigational compounds, and for the identification of new target selectivities for drug repurposing applications.Item Learning with multiple pairwise kernels for drug bioactivity prediction(2018-07-01) Cichonska, Anna; Pahikkala, Tapio; Szedmak, Sandor; Julkunen, Heli; Airola, Antti; Heinonen, Markus; Aittokallio, Tero; Rousu, Juho; Department of Computer Science; Professorship Rousu Juho; Helsinki Institute for Information Technology (HIIT); Professorship Lähdesmäki Harri; Centre of Excellence in Molecular Systems Immunology and Physiology Research Group, SyMMys; University of Turku; Aalto UniversityMotivation: Many inference problems in bioinformatics, including drug bioactivity prediction, can be formulated as pairwise learning problems, in which one is interested in making predictions for pairs of objects, e.g. drugs and their targets. Kernel-based approaches have emerged as powerful tools for solving problems of that kind, and especially multiple kernel learning (MKL) offers promising benefits as it enables integrating various types of complex biomedical information sources in the form of kernels, along with learning their importance for the prediction task. However, the immense size of pairwise kernel spaces remains a major bottleneck, making the existing MKL algorithms computationally infeasible even for small number of input pairs. Results: We introduce pairwiseMKL, the first method for time- and memory-efficient learning with multiple pairwise kernels. pairwiseMKL first determines the mixture weights of the input pairwise kernels, and then learns the pairwise prediction function. Both steps are performed efficiently without explicit computation of the massive pairwise matrices, therefore making the method applicable to solving large pairwise learning problems. We demonstrate the performance of pairwiseMKL in two related tasks of quantitative drug bioactivity prediction using up to 167 995 bioactivity measurements and 3120 pairwise kernels: (i) prediction of anticancer efficacy of drug compounds across a large panel of cancer cell lines; and (ii) prediction of target profiles of anticancer compounds across their kinome-wide target spaces. We show that pairwiseMKL provides accurate predictions using sparse solutions in terms of selected kernels, and therefore it automatically identifies also data sources relevant for the prediction problem.Item Menetelmä ja laitteisto hitsauskoneiden pölytestaukseen(2016-06-13) Airola, Antti; Malinen, Jarkko; Insinööritieteiden korkeakoulu; Ekman, KaleviItem Pneumaattiset materiaalinkuljetusjärjestelmät(2013-04-24) Airola, Antti; Saarikoski, Tuomas; Insinööritieteiden korkeakoulu; Pietola, Matti